L1 Capital Global Opportunities Master Fund, Ltd. 13D and 13G filings for ENDRA Life Sciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:04 pm Purchase |
2024-12-31 | 13G | ENDRA Life Sciences Inc. NDRA |
L1 Capital Global Opportunities Master Fund, Ltd. | 35,589 6.220% |
31,062 (+686.21%) |
Filing |
| 2024-06-14 08:00 am Purchase |
2024-06-04 | 13G | ENDRA Life Sciences Inc. NDRA |
L1 Capital Global Opportunities Master Fund, Ltd. | 4,527 9.990% |
4,527 (New Position) |
Filing |